For AI-powered Gene Therapy
and Product Development.
——Westlake Genetech. Ltd.
Company Profile
About US
Westlake Genetech. Ltd. is an innovative biotech company. By building AI-driven gene therapy platforms and developing differentiated self-developed gene therapy products, the company is committed to advancing the full-process implementation of AI-powered gene therapy.
Technology Platform
TECHNOLOGY
News
NEWS
10-07
2025
Westlake Genetech Invited to Present at 2025 ESGCT Annual Meeting
Westlake Genetech has been invited to attend and deliver an on-site presentation at the 32nd Annual Meeting of the European Society of Gene and Cell Therapy (ESGCT), to be held at Fibes in Seville, Spain, from October 7 to 10, 2025 (local time).
09-10
2025
Westlake Genetech Wins Championship at 2025 Novo Nordisk x ATLATL EntreStar
On September 10, 2025, the 2025 EntreStar Innovation Competition, co-hosted by Novo Nordisk China R&D Center and ATLATL Innovation Center, concluded successfully in Shanghai.
Launched in March 2025, the competition narrowed down to five outstanding innovative teams for the finals following a rigorous preliminary round. Westlake Genetech stood out as the champion with its exceptional project performance.
01-10
2025
01-09
2025
05-06
2024
Westlake Genetech to Showcase Two Research Achievements at 2024 ASGCT Annual Meeting
2024
Westlake Genetech. Ltd. announced participation in the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), to be held at the Baltimore Convention Center in Baltimore, Maryland, from May 7 to 11, 2024 (Eastern Time, USA).
The company will deliver two oral presentations, highlighting its leading AAV gene therapy delivery platform and its AAV targeting CNS and muscle, and in vivo CAR-T therapy.
